Curran Terrie Insider Trades

Insider Trading History

Track insider trading activity for Curran Terrie. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Arcutis Biotherapeutics
Arcutis Biotherapeutics ARQT
Director
Holding Value $644k 23,526 shares
Last Trade
Jun 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$477k 22,445 shares
$21.23
$27.39
Arcutis Biotherapeutics
Arcutis Biotherapeutics ARQT
Director
Holding Value $563k 20,568 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$278k 20,568 shares
$13.50
$27.39
Phathom Pharmaceuticals
Phathom Pharmaceuticals PHAT
President And Chief Executive
Holding Value $3.63M 342,500 shares
Last Trade
Feb 27, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.97M 342,500 shares
$5.76
$10.61
Phathom Pharmaceuticals
Phathom Pharmaceuticals PHAT
President And Chief Executive
Holding Value $3.82M 360,465 shares
Last Trade
Jan 21, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$126k 19,109 shares
$6.59
$10.61
Arcutis Biotherapeutics
Arcutis Biotherapeutics ARQT
Director
Holding Value $278k 10,139 shares
Last Trade
Nov 11, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$94.3k 8,687 shares
$10.85
$27.39
Phathom Pharmaceuticals
Phathom Pharmaceuticals PHAT
President And Chief Executive
Holding Value $4.01M 377,734 shares
Last Trade
Jul 15, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$397k 33,848 shares
$11.72
$10.61
Arcutis Biotherapeutics
Arcutis Biotherapeutics ARQT
Director
Holding Value $741k 27,052 shares
Last Trade
Jun 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$233k 27,052 shares
$8.63
$27.39
Phathom Pharmaceuticals
Phathom Pharmaceuticals PHAT
President And Chief Executive
Holding Value $4.36M 410,784 shares
Last Trade
Mar 22, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$186k 16,851 shares
$11.02
$10.61
Phathom Pharmaceuticals
Phathom Pharmaceuticals PHAT
President And Chief Executive
Holding Value $5.04M 475,000 shares
Last Trade
Jan 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.61M 475,000 shares
$7.60
$10.61
Phathom Pharmaceuticals
Phathom Pharmaceuticals PHAT
President And Chief Executive
Holding Value $4.53M 427,171 shares
Last Trade
Nov 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$360k 37,500 shares
$9.61
$10.61
Phathom Pharmaceuticals
Phathom Pharmaceuticals PHAT
President And Chief Executive
Holding Value $0 0 shares
Last Trade
Jul 14, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$5.62M 400,000 shares
$14.06
$10.61
Phathom Pharmaceuticals
Phathom Pharmaceuticals PHAT
President And Chief Executive
Holding Value $4.13M 389,671 shares
Last Trade
Jul 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.81M 200,000 shares
$14.06
$10.61
Arcutis Biotherapeutics
Arcutis Biotherapeutics ARQT
Director
Holding Value $335k 12,220 shares
Last Trade
May 31, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$91.8k 12,220 shares
$7.51
$27.39
Phathom Pharmaceuticals
Phathom Pharmaceuticals PHAT
President And Chief Executive
Holding Value $2M 188,290 shares
Last Trade
Apr 06, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$101k 12,919 shares
$7.82
$10.61
Myovant Sciences
Myovant Sciences MYOV
Director
Holding Value $0 0 shares
Last Trade
Mar 10, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.92M 71,173 shares
$26.98
$26.98
Phathom Pharmaceuticals
Phathom Pharmaceuticals PHAT
President And Chief Executive
Holding Value $1.86M 175,371 shares
Last Trade
Mar 01, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$12.3k 1,436 shares
$8.54
$10.61
Phathom Pharmaceuticals
Phathom Pharmaceuticals PHAT
President And Chief Executive
Holding Value $1.88M 176,807 shares
Last Trade
Jan 20, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$47.7k 5,821 shares
$8.20
$10.61
Phathom Pharmaceuticals
Phathom Pharmaceuticals PHAT
President And Chief Executive
Holding Value $888k 83,720 shares
Last Trade
Nov 21, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$14.6k 1,526 shares
$9.60
$10.61
Myovant Sciences
Myovant Sciences MYOV
Director
Holding Value $266k 9,859 shares
Last Trade
Oct 26, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$264k 9,859 shares
$26.80
$26.98
Phathom Pharmaceuticals
Phathom Pharmaceuticals PHAT
President And Chief Executive
Holding Value $904k 85,246 shares
Last Trade
Sep 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$65.6k 7,500 shares
$8.74
$10.61

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up